Galderma Group AG agreed to acquire ZO Skin Health Inc. from Blackstone Tactical Opportunities and the Obagi family for an enterprise value of $1.5 billion. The all-cash transaction buys a...
BlackRock entered an agreement on October 13, 2026, to acquire the majority equity stake in a primary care joint venture from Welsh, Carson, Anderson & Stowe for $2.8 billion. The transaction...
STERIS Corporation, a wholly owned operating subsidiary of STERIS plc, agreed to buy Xodus Medical, Inc. for $2.1 billion in cash on October 12, 2026, according to a corporate press release...
Viatris Inc. agreed to purchase Pacira BioSciences Inc. for $36.50 per share in cash on October 8, 2026, establishing an equity valuation of approximately $1.65 billion. The transaction establishes...
Shionogi & Co., Ltd. agreed to acquire IntraBio Inc. for $2.0 billion in an all-cash transaction announced on October 5, 2026. The Japanese pharmaceutical company will purchase 100 percent of the...
GE HealthCare announced on October 5, 2026, that it agreed to purchase SOFIE Biosciences from private equity firm Trilantic North America for $945 million in cash. SOFIE Biosciences operates as a...
Spire Healthcare Group agreed on September 5, 2026, to a £1.03 billion cash takeover by Tulip UK Bidco, an investment consortium led by hedge fund manager Toscafund Asset Management alongside THCP...
AbbVie (NYSE: ABBV) today announced the successful completion of its acquisition of Apogee Therapeutics (NASDAQ: APGE), an all-cash transaction valued at approximately $10.9 billion. Under the terms...
In a strategic maneuver to solidify its presence beyond the metabolic health sector, Eli Lilly and Company (NYSE: LLY) announced on August 31, 2026, a definitive agreement to acquire Merida...
In a definitive move to dominate the rapidly expanding nuclear medicine landscape, Curium US Holdings has entered into a definitive agreement to acquire Lantheus Holdings, Inc. (NASDAQ: LNTH) for a...
